Treace Medical Concepts Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-49.53	-42.82	-20.75	-4.31	-4.91
Depreciation & Amortization	7.81	4.66	0.69	1.21	0.79
Share-Based Compensation	17.35	8.11	3.41	0.92	0.82
Other Operating Activities	-10.21	-0.6	-0.74	-2.96	-5.02
Operating Cash Flow	-34.58	-30.65	-17.19	-4.49	-7.67
Capital Expenditures	-11.46	-14.84	-2.71	-1.07	-1.21
Acquisitions	-20	0	0	0	0
Change in Investments	-49.84	-61.68	0	0	0
Investing Cash Flow	-81.3	-76.52	-2.71	-1.07	-1.21
Share Issuance / Repurchase	109.4	2.19	109.44	0.36	0.07
Debt Issued / Paid	0	18.62	-1.79	11.14	19.67
Other Financing Activities	-0.01	-	-	-	-
Financing Cash Flow	109.38	20.81	107.65	11.5	19.74
Net Cash Flow	-6.49	-86.36	87.75	5.94	10.86
Free Cash Flow	-46.03	-45.49	-19.9	-5.56	-8.88
Free Cash Flow Margin	-24.60%	-32.07%	-21.07%	-9.70%	-22.54%
Free Cash Flow Per Share	-0.76	-0.82	-0.41	-0.15	-0.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).